← Issue №5/ week of Aug 2, 2026/Motility

Possible Mechanisms Underlying the Effects of Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome.

From GI Signals issue №5: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Motility prospective cohort · n=93 · Jul 30, 2026 · J Neurogastro Motil · IF 3.4

Possible Mechanisms Underlying the Effects of Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome.

Basic sciencemicrobiomebasic sciencetranslationalbiomarker
Clinical takeawayNo clinical action yet: a mechanistic finding in IBS patients post-FMT, suggesting pathways for future therapy but no current intervention.
What it foundFMT increased stem cells, enteroendocrine progenitors, serotonin, GLP-1, and PYY cells, decreased immune and mast cells, and raised fecal butyrate, all inversely correlating with IBS symptoms and fatigue.
ContextRefines understanding of FMT's potential mechanisms in IBS, linking microbiota changes to gut cell and immune modulation, but does not yet translate to clinical practice.
Emergingsuggested applicable standard· American Gastroenterological Association, Chey WD, Hashash JG, Manning L, Chang L. "AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review." Gastroenterology. 2022;162(6):1737-1745 (doi:10.1053/j.gastro.2021.12.248; PMID 35337654)

Decision at stakethe role of fecal microbiota transplantation in IBS management

Per AGA best practice advice: dietary intervention is most appropriate for IBS patients who have insight into meal-related symptoms and are motivated to make dietary changes. Soluble fiber (e.g., psyllium/ispaghula) is efficacious for global IBS symptoms and is a reasonable initial option, most suitable in constipation-predominant IBS; insoluble fiber (wheat bran) is NOT.

From our summary of this standard, unedited — the part the paper bears on. marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

Per AGA best practice advice: dietary intervention is most appropriate for IBS patients who have insight into meal-related symptoms and are motivated to make dietary changes. Soluble fiber (e.g., psyllium/ispaghula) is efficacious for global IBS symptoms and is a reasonable initial option, most suitable in constipation-predominant IBS; insoluble fiber (wheat bran) is NOT. The low-FODMAP diet is currently the most evidence-based diet intervention for IBS and is delivered as a structured 3-phase protocol, NOT lifelong restriction: (1) restriction of high-FODMAP foods lasting NO MORE than 4-6 weeks, (2) reintroduction of FODMAP foods, and (3) personalization based on reintroduction results. Any specific diet intervention should be attempted for a predetermined length of time; if there is no clinical response, the diet should be ABANDONED and a different diet or therapy tried, rather than continued indefinitely. Refer willing and appropriate patients to a GI registered dietitian nutritionist (RDN) to implement and supervise the diet. Poor candidates for restrictive diet interventions include patients who already consume few culprit foods, those at risk for malnutrition, those who are food insecure, and those with an eating disorder or uncontrolled psychiatric disorder; routine screening for disordered eating/eating disorders by careful dietary history is critical before starting a restrictive diet.

American Gastroenterological Association, Chey WD, Hashash JG, Manning L, Chang L. "AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review." Gastroenterology. 2022;162(6):1737-1745 (doi:10.1053/j.gastro.2021.12.248; PMID 35337654) · reviewed 2026-07-19 ↗
El-Salhy M … Hatlebakk JG · Journal of Neurogastroenterology and Motility · IF 3.4 · PubMed ↗Permalink
← Read the whole of issue №5 Every paper GI Signals surfaces gets a page like this one. All issues